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A rat model of Varicella–Zoster virus (VZV) provides a system in which to investigate the molecular determinants of viral latency in
dorsal root ganglia (DRG). In this study, we determined whether the VZV glycoproteins gC and gI, corresponding to VZV open reading
frames (ORFs) 14 and 67, respectively, were required for the establishment of latency in this model. AVZV gI deletion mutant (DgI) derived
from a recombinant Oka (rOka) cosmid and a gC null mutant obtained from a clinical isolate were inoculated into the footpads of 6-week-old
rats, and the presence of viral DNA and eight different VZV RNA transcripts corresponding to the three classes of genes was investigated by
in situ RT-PCR amplification and in situ hybridization (ISH) in the DRG at 1 week, 1 month, and 18–24 months after infection. VZV DNA
and restricted RNA expression was established with both deletion mutants as well as the parental rOka virus. Both VZV DNA and RNAwere
detected in neurons and non-neuronal cells. The pattern of viral RNA expression detected with both gC and gI mutants was restricted with
transcripts for VZV genes 62 and 63 most frequently expressed 18–24 months after infection. Transcripts for VZV genes 18, 28, and 29 were
also detected at these time points but at a slightly lower frequency. Transcripts for the late gene 40 were never detected. We conclude that
VZV ORFs 14 and 67 are dispensable for the establishment of a latent infection in this model.
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Varicella–Zoster virus (VZV) is an important human
herpesvirus causing a primary infection known as varicella
(also called chicken pox) following which the virus
becomes latent in the trigeminal ganglia (TG) and dorsal
root ganglia (DRG) (Gilden et al., 2000; Kennedy, 2002).
After a variable interval that may be many years, the virus
may reactivate, either spontaneously or following one or
more triggering factors, to produce herpes zoster (also
known as shingles) (Gilden et al., 2000). The latter is an
extremely painful condition that may be followed by post-
herpetic neuralgia (PHN), and viral reactivation may also
be associated with a variety of other serious neurological
conditions (Gilden et al., 2000). PHN has a highly signif-0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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nedy, 2002) so that a better understanding of the molecular
determinants of the latency process is an important goal of
VZV research. It has been established that during VZV
latency in human TG and DRG, the virus is located
predominantly in neuronal cells (Kennedy et al., 1998,
LaGuardia et al., 1999; Lungu et al., 1995), and at least
six viral genes (ORFs 4, 21, 29, 62, 63, and 66) have now
been shown to be expressed in ganglia during latent
infection (Cohrs et al., 1994, 1995, 1996, 2003; Croen et
al., 1988; Kennedy et al., 2000).
Although it has been problematic for various reasons to
establish ideal animal models of VZV latency, the adult rat
model of VZV latency has proved to be a useful tool in
modeling latency establishment (Sadzot-Delvaux et al.,
1990), viral gene expression during latency (Kennedy et
al., 2001), and PHN (Fleetwood-Walker et al., 1999).
Although in this rat model, the localization of viral compo-
nents in neuronal and non-neuronal cells differs form the
mostly exclusive neuronal localization in human ganglia,
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human latency in terms of restricted viral gene expression
because it is characterized by a limited expression of
immediate and immediate-early genes while late genes
remain silent (Debrus et al., 1995). Despite these differences
from some aspects of human latency, the absence of
expression of transcripts corresponding to late genes argues
for the rodent system modeling latency rather than a
persistent ganglionic infection. Other animal models of
VZV latency have also been described in guinea pigs
(Lowry et al., 1983), mice (Wroblewska et al., 1993), and
neonatal rats (Brunell et al., 1999). Highly relevant to the
present study, the use of viral deletion mutants has allowed
the dispensability or otherwise of specific viral genes in the
establishment of putative latency to be investigated in rat
models. A recent example of the latter reported that VZV
open reading frame (ORF) 21, which is expressed during
human latency, is nevertheless dispensable for the establish-
ment of latency in a cotton rat model (Xia et al., 2003). The
VZV glycoproteins gC and gI correspond to the viral ORFs
14 and 67, respectively, and their functional roles have been
investigated using DgC and DgI mutants derived, respec-
tively, from a clinical isolate and a recombinant Oka (rOka)
obtained from the cosmids technology, respectively (Mal-
lory et al., 1997; Moffat et al., 1998). Studies of these
mutants have shown that both gC and gI are dispensable for
viral replication in tissue culture (Mallory et al., 1997;
Moffat et al., 1998). However, studies in the SCID-hu
mouse model showed that gC plays a crucial role in the
virulence of VZV for human skin (Moffat et al., 1998). It
has also been shown that gI is required for efficient
membrane fusion during VZV replication (Mallory et al.,
1997), as well as VZV infectivity in human skin and T cells
(Moffat et al., 2002). In the current study, we used a rat
model to determine whether ORFs 14 and 67 are required or
dispensable for the establishment of a latent VZV infection.Results and discussion
In this study, we used both in situ PCR amplification
(ISPCR) and in situ hybridization (ISH) to detect VZV DNA,
and ISH alone to detect RNA corresponding to eight different
VZV genes corresponding to the three classes of genes:
transcripts corresponding to ORF 4, 62, and 63 (immediate
early genes), ORF 18, 21, 28, and 29 (early genes), and ORF
40 (late gene) have been searched for in a total of 27 DRG
samples obtained from 20 rats that had received footpad
inoculation with different mutant VZV. The DRG were
studied at three different times—1 week, 1 month, and 18–
24 months post-infection. A total of six rats were studied at 1
week, seven rats at 1 month, and seven rats at 18–24 months
after infection. The rats had been mainly inoculated with
either the DgC (n = 5) or the DgI VZV mutant (n = 7), but a
few rats had been inoculated with the parental rOka virus
strain (n = 4) or the repaired gI (DgI@Avr) virus (n = 4). Thedetailed results of this study are shown in Table 1. The two
techniques were not applied to every specimen because of
differing availabilities of the DRG tissues, and more tissues
from some time points were available, and therefore studied,
than others.
At the 1-week time point, VZV DNAwas detected in the
one rOka-inoculated in all the DgI-infected and DgI@Avr-
inoculated DRG, but not in the one DgC sample studied at
this time point.
At 1 month post-infection, VZV DNA was detected in
one of the two rOka-inoculated DRG as well as one of each
of the two DgI-inoculated and DgI@Avr-inoculated DRG. A
DgC-inoculated sample was not available at this time point.
At the 18-month time point, VZV DNA was detected in
three of the six DgI-inoculated DRG, and at the 2-year time
point, VZV DNA was detected in four of the eight DgC-
inoculated DRG. No rOka or revertant viruses were studied
at these later times. The two techniques usually gave the
same results—either negative or positive—but this was not
always the case as in samples 1 and 20, presumably because
of the greater sensitivity of ISPCR compared with ISH in
case 1, and possibly tissue sampling variability in case 20.
VZV DNA was not detected in any of the control non-
inoculated tissues or, in ISPCR, the incorporation of non-
sense primers or the absence of primers (data not shown).
However, the positive control, consisting of a latently
infected human TG sample, was positive using these tech-
niques (Kennedy et al., 1998). In all the rat DRG studies, the
VZV DNA signal was located within both the neuronal
nuclei, and non-neuronal satellite cells (Fig. 1). Only a small
proportion of the total number of neurons was positive,
approximately 2–5%, but accurate quantitation was not
possible because of the marked focal variability of positive
staining.
The profile of RNA expression in the DRG was also
analyzed. At the 1-week time point, RNA for VZV gene 63
was detected in one of the two rOka-inoculated samples,
RNA for VZV genes 29 and 62 was detected in the one
DgC-inoculated DRG, RNA for VZV genes 29, 62, and 63
was detected in the one DgI-inoculated samples, and RNA
for VZV genes 62 and 63 was detected in the two gI repair-
inoculated samples. At the 1 month post-inoculation time
point, RNA for VZV gene 18 was detected in one of two
rOka-inoculated samples, RNA for VZV genes 4, 21, 29,
62, and 63 was detected in one of three DgI-inoculated
samples, and RNA for VZV genes 29, 62, and 63 were
detected in one of two gI repair-infected DRG.
At the 18-month time point for DgI-inoculated DRG,
RNA for VZV genes 18, 21, 28, 29, 62, and 63 were
detected in one sample, genes 4, 28, 62, and 63 in another,
and genes 18, 29, and 62 in the third.
At the 2-year time point for DgC-inoculated DRG, RNA
for VZV genes 62 and 63 was detected in one sample, and
for genes 18, 62, and 63 in another. Thus, the most
frequently expressed genes at this later time point in all
the inoculated DRG were VZV genes 62 and 63. VZV gene
Table 1
Detection by of VZV RNA and DNA in infected rat DRG*
Detection of VZV RNA corresponding to genes VZV DNA detection by
Gene deletion Region Gene 4 Gene 18 Gene 21 Gene 28 Gene 29 Gene 40 Gene 62 Gene 63 ISPCR ISH
(1) rOka 1wpi lumbar        + + 
(2) rOka 1wpi lumbar ND  ND ND ND ND    
(3) DgC 1wpi lumbar     +  +   ND
(4) DgI 1wpi lumbar ND   ND +  + + + 
(5) DgI@Avr 1wpi lumbar ND ND  ND ND ND + ND + ND
(6) DgI@Avr 1wpi lumbar  ND     + + + ND
Number RNA positive/
number tested
0/3 0/4 0/5 0/3 2/4 0/4 4/6 3/5
(7) rOka 1mpi lumbar ND   ND      ND
(8) rOka 1mpi lumbar ND +  ND     + +
(9) DgI 1mpi lumbar +  +  +  + + + +
(10) DgI 1mpi lumbar ND   ND      ND
(11) DgI 1mpi lumbar ND ND ND ND ND ND   + ND
(12) DgI@Avr 1mpi lumbar ND         ND
(13) DgI@Avr 1mpi lumbar ND  ND ND + ND + + + +
Number RNA positive/
number tested
1/1 1/6 1/5 0/2 2/6 0/5 2/7 2/7
(14) DgC 2yrpi lumbar ND   ND      ND
(15) DgC 2yrpi lumbar ND ND  ND  ND  ND  
(16) DgC 2yrpi thoracic ND  ND   ND  ND  ND
(17) DgC 2yrpi lumbar ND ND ND ND ND ND ND ND + +
(18) DgC 2yrpi lumbar    ND   + + + +
(19) DgC 2yrpi thoracic      ND    ND
(20) DgC 2yrpi thoracic  +   ND ND + +  +
(21) DgC 2yrpi thoracic   ND      + +
(22) DgI 18mpi lumbar  + + + +  + + + +
(23) DgI 18moi lumbar ND ND ND ND ND ND ND ND  
(24) DgI 18mpi lumbar ND   ND   ND   
(25) DgI 18mpi thoracic ND         
(26) DgI 18mpi thoracic +   + ND ND + + ND +
(27) DgI 18mpi thoracic  +  ND +  +  + +
Number RNA positive/
number tested
1/7 3/11 1/10 2/7 2/10 0/7 5/11 4/10
*DRG = dorsal root ganglion; 1wpi = 1 week post-inoculation; 1mpi = 1 month post-inoculation; 18mpi = 18 months post-inoculation; + = positive;  =
negative; ND = not determined; ISPCR = in situ PCR amplification; ISH = in situ hybridization.
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detected. VZV RNAwas not detected in any of the negative
controls, for example, using sense ISH probes (data not
shown), but was detected in latently infected human TG.
Viral DNA and RNA was detected in many neuronal nuclei
as well as non-neuronal satellite cells (Fig. 1), although it
was our impression that viral DNA was present in more
neurons than was the case for RNA. However, it was very
difficult to quantify this because of the highly focal distri-
bution but at least half of the positive cells were non-
neuronal; in some cases more than half and in others,
neuronal staining was more evident.
We also carried out an independent series of experiments
to look for viral components in other tissues to verify that
latency was limited to the peripheral nervous system as is
the case in humans. Three additional rats were inoculated in
the footpad with wild-type VZV, and the DRG were
removed 3 months later along with spleen, liver, lung, and
kidney tissue samples from each of the rats. PCR analysis
using primers for both VZV genes 62 and 63 was carried out
on all these samples. Despite the detection of VZV DNA inDRG from each of the animals, only 1 out of 13 systemic
tissue samples was found to be positive (spleen, with gene
62 primers only), while all samples were negative for VZV
gene 63 by PCR and positive for h-actin (data not shown).
This result strongly indicates that a true latent VZV infection
had been established in the DRG of these rats.
These results raise several interesting issues pertaining to
VZV infection in the rat DRG. They demonstrate that both
the gC and gI VZV deletion mutants were able to infect
neuronal and non-neuronal cells as wild type and rOka
viruses do, and to establish a latent infection in this rat
model. In both cases, viral DNA was detectable within the
DRG at 18–24 months after footpad inoculation, and in the
DgI mutant, viral DNAwas also detected after 1 month. We
detected RNA corresponding to several known human
latency-associated genes at these time points, in particular,
VZV genes 63, 62. The results with the revertant and
parental rOka viruses were few in number but were consis-
tent with the other results. This profile of VZV gene
transcription mirrors in part that previously detected in both
human (Kennedy et al., 2000) and rat studies (Kennedy et
Fig. 1. Molecular hybridization to localize VZV nucleic acids in latently infected rat and human ganglia. (A) Shows DNA ISH with a VZV gene 37 probe on a
rat DRG that had been inoculated with the gC-minus mutant at 2-year post-inoculation. Positive signals are seen in several neuronal nuclei as well as non-
neuronal satellite cells. (B) Shows the same DRG as in A on which RNA ISH with a VZV gene 63 probe was performed. Positive signals are again seen in
several neuronal nuclei and non-neuronal satellite cells. (C) Shows RNA ISH for VZV gene 62 on a rat DRG that had been inoculated with the gI-minus mutant
at 18 month post-inoculation. Positive signals are seen in several neurons and non-neuronal satellite cells. (D) Shows RNA ISH with a VZV gene 63 probe on a
normal human trigeminal ganglion. A positive signal is seen in a neuronal nucleus (original magnification captured at 450).
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VZV gene 28 in two DRG may reflect actual differences
between rodent and human latency, the focal nature
of transcript detecting these assays, or possibly areas of
localized viral reactivation. However, the absence of late
VZV gene expression such as gene 40 is against the latter
possibility. Further, there was no evidence of tissue necrosis
in the sections that might be expected to occur in the late
stages of viral reactivation. The finding of transcription of
VZV genes 4 and 18 in some cases was perhaps not
unexpected as this is consistent with previous observations
(Croen et al., 1988; Kennedy et al., 2000).
In general, there was a good correlation between DNA
detection and detection of at least one viral transcript in the
DRG. However, this was not always the case as, for
example, in sample number 21 where VZV DNA was
detected in the absence of viral RNA. This may reflect
sampling error, relative abundance of RNA due to tissue
breakdown, or probably less likely, very limited viral
transcription in this case. Although the presence of VZV
DNA in neuronal nuclei with both of the mutants is
consistent with the viral cell specificity seen in human
ganglia (Kennedy et al., 1998, 1999) as well as wild-type
VZV in rat DRG (Kennedy et al., 2001), it was of interest
that more non-neuronal satellite cells contained viral DNA
and RNA compared with our previous study using this
model. This may reflect a small biological differencebetween wild-type and mutant VZV strains or else primar-
ily a difference due to sampling variations. This also
contrasts with human VZV ganglionic latency where both
viral DNA and RNA are located predominantly in neurons
(Kennedy et al., 1998, 1999, 2000). This has recently been
confirmed by a study that detected occasional VZV RNA
signals in satellite cells in addition to neuronal nuclei in
latently infected human TG (Theil et al., 2003). The
different global appearance of the positive signals in rat
and human ganglia shown in Fig. 1 may also suggest
differences between rat and human latency. The detection
of virus in several thoracic ganglia deserves comment in
view of the footpad site of inoculation. This could be
explained if a viremia had occurred after inoculation,
allowing virus to reach some thoracic ganglia by means
other than axonal transport. Although it would have been
ideal to have used cell-free virus in this study, especially as
it would have been less likely to have replicated at the local
site of inoculation, this was not possible as the high viral
titers necessary to establish latency in this model are not
readily achievable.
Our results show that VZV ORFs 14 and 67 are dispens-
able for the establishment of a latent infection in this rat
model. This implies that the genetic factors determining
VZV virulence in the skin are different from those control-
ling latency in the DRG. Because both ORFs 14 and 67 are
dispensable for viral replication in tissue culture, it is not
E. Grinfeld et al. / Virology 323 (2004) 85–90 89possible to make any extrapolations regarding the require-
ment for viral replication before establishment of latency.
Although neither of these VZV genes are known so far to be
latency-associated in humans, it has recently been estab-
lished that VZV ORF 21, which is latency-associated in
humans, is also dispensable for putative latency establish-
ment in a rat model (Xia et al., 2003) so clearly the
functional roles of such associated genes has yet to be
clarified—an epiphenomenon role of some of these genes
has yet to be excluded. However, one or more VZV genes
presumably may play a role in viral reactivation although
this is difficult to investigate further at present in the
absence of an animal model of VZV reactivation.
It is clearly crucial to know whether the detection of viral
transcripts in this rat model infected with mutants reflects
true latency or a persistent ganglionic infection. Strongly in
favor of latency in this rat model is the presence, at these
later time points after inoculation, of VZV DNA in DRG at
1–24 months after footpad inoculation, and the expression
of several viral transcripts, some of which such as VZV
genes 63 and 62, is also expressed during human latency,
although transcripts to a late gene have never been detected
as is also the case in human VZV latency. However, unlike
human latency, viral DNA and RNA were present in many
non-neuronal satellite cells as well as neurons, and we also
detected VZV ORF 28 that is not associated with human
latency. ORF 18 transcription was detected in several rat
ganglia; this transcript was also detected in a minority
of human ganglia in one study (Kennedy et al., 2000).
Previous models of persistent ganglionic infections have
used corneal inoculation of mice with VZV (Wroblewska et
al., 1993) and intratracheal inoculation of simian varicella
virus into monkeys (White et al., 2002). In these models,
multiple organs were infected and multiple transcripts
including transcripts corresponding to late genes were
detected for months after infection, and both of these models
are now recognized as mirroring persistent infections rather
than latency. However, the combined results obtained in the
present study, in particular, the absence of detection of VZV
DNA in the systemic tissues, argue for the establishment of
true latency in the rats, although clearly the phenotypes of
human and rat latency are not the same. The results
described here show that in this rat model, two particular
VZV genes are not required for the establishment of latency
in the DRG.Methods
Animal inoculations
These were carried out as previously described in
detail (Sadzot-Delvaux et al., 1990). In brief, 6-week-old
healthy rats were inoculated on both sides in the footpad
with suspensions of one of the four different VZV
isolates. Uninfected rat liver tissues were used as negativecontrols. Rats were sacrificed at 1 week, 1 month, 18
months, or 24 months after inoculation, and the lumbar
and thoracic DRG were removed, fixed in formalin, and
embedded in wax for the ISPCR and ISH procedures. In a
separate experiment, three rats were used to look for viral
DNA in systemic tissues as well at 3 months post-
inoculation. Different amounts of DRG tissues were
available for each time point. The rOka, rOka-DgI, and
gC null viruses used in these experiments have been
previously described in detail (Mallory et al., 1997;
Moffat et al., 1998). The gC-Oka virus is a naturally
occurring variant that was plaque purified from V-Oka
and was kindly provided by Lawrence Gelb, Washington
University, St. Louis, MO, USA.
In situ PCR and in situ hybridization
These techniques were carried out as described in detail
(Kennedy et al., 1998, 2000). ISPCR was performed using
digoxygenin-labeled dUTP and primers for VZV gene 62 as
previously documented (Kennedy et al., 1998). A positive
control was provided by a known VZV latently infected TG
in which VZV DNA gene 62 was amplified. Negative
controls consisted of the inclusion of nonsense primers
during the reaction, omission of primers, and uninfected
rat DRG tissues.
ISH was also carried out as previously documented using
digoxygenin-labeled probes for the 8 VZV genes mentioned
in the text. The probe sequences were as previously de-
scribed (Kennedy et al., 2000). Anti-sense and sense ori-
ented probes acted as positive and negative probes,
respectively. Positive and negative control tissues were as
for ISPCR. For both techniques, each DRG was studied at
least twice for each gene.
PCR
DRG and peripheral tissues (lung, liver, spleen, and
kidney) from three rats inoculated as described previously
were removed after 3 months. The DRG (lumbar and
thoracic) were fixed and paraffin embedded as described,
and the peripheral tissues snap frozen. DNA was extracted
using a Qiagen DNeasy tissue kit. PCR was performed on
all tissues using primers for VZV gene 63 (850 bp
product), VZV gene 62 (277 bp product), and h-actin
(182 bp product). Primer sequences were as described
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